Cannabis--clinical pharmacology
Retterstol, N.
Tidsskrift for den Norske Laegeforening Tidsskrift for Praktisk Medicin Ny Raekke 93(28): 2125-2126
1973
ISSN/ISBN: 0029-2001 PMID: 4590073 Document Number: 64342
Document emailed within 1 workday
Related Documents
Mason, A.P.; McBay, A.J. 1985: Cannabis: pharmacology and interpretation of effects Journal of Forensic Sciences 30(3): 615-631Vyas, B. 2001: European Association of Clinical Pharmacology and Therapeutics--Fifth Congress. Clinical pharmacology: from molecule to society--bridging the gap via Man IDrugs: the investigational drugs journal 4(10): 1133-1137
Poulsen, H.Enghusen.; Schmitz, O.E.; Brøsen, K. 2002: Clinical pharmacology 2001--important events. The Danish Society of Clinical Pharmacology Ugeskrift for laeger 164(12): 1652
Duchêne-Marullaz, P. 1977: Pharmacology, clinical pharmacology and therapeutic effects of Royat's thermal gas Semaine des Hopitaux. Therapeutique 53(7-8): 361-362
Levy, S.; Jones, A. 2000: Improving the debate on cannabis. the effects of cannabis on driving are difficult to evaluate Bmj 320(7250): 1671-1672
Subbaraman, M.S.; Kerr, W.C. 2018: Alcohol use and Risk of Related Problems Among Cannabis Users Is Lower Among those with Medical Cannabis Recommendations, Though not Due to Health Journal of Studies on Alcohol and Drugs 79(6): 935-942
Ono, M.; Shimamine, M.; Takahashi, K. 1972: Studies on cannabis. 3. Distribution of tetrahydrocannabinol in the cannabis plant Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 90: 1-4
Copeland, J. 2016: Cannabis use and its associated disorders: Clinical care Australian Family Physician 45(12): 874-877
Kenchadze, V.G.; Chkoniia, E.D. 2006: Clinical features of cannabis psychosis in schizophrenia patients Georgian Medical News 137: 55-58
Demchenko, V.T.; Kantariia, V.A.; Kerimov, B.L.; Shogentsukova, E.A.; Shomakhova, N.S. 1984: Clinical pharmacology and clinical pharmacy in a general clinical hospital Sovetskoe Zdravookhranenie 9: 27-29
Moiseev, V.S.; Lepakhin, V.K. 1989: Clinical pharmacology and problems of drug therapy in the clinical picture of internal diseases Terapevticheskii Arkhiv 61(8): 6-10
Simić, D.; Vrhovac, B. 1978: Clinical pharmacology: its importance, place, and role in larger clinical centers Medicinski Pregled 31(9-10): 403-408
Brandão, F.; Polónia, J. 1992: Clinical trials in cardiovascular clinical pharmacology Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(3): 273-281
Russo, E.B. 2008: Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? Neuro Endocrinology Letters 29(2): 192-200
Russo, E.B. 2004: Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? Neuro Endocrinology Letters 25(1-2): 31-39
Lunde, P.K. 1970: Clinical pharmacology Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 90(24): 2282-2284
Gattoni, A.; De Donato, M.T.; Catalano, G.; Astarita, C.; Bernabò, R.; Altucci, P. 1982: D(-)penicillamine: pharmacology and clinical uses La Clinica Terapeutica 103(4): 411-444
Konturek, S.J. 1982: Pharmacology and clinical use of ranitidine Mount Sinai Journal of Medicine new York 49(5): 370-382
Benjamin, R.S. 1981: Clinical pharmacology of daunorubicin Cancer Treatment Reports 65(Suppl 4): 109-110
Burmeister, W. 1970: Clinical pharmacology in paediatrics Internationale Zeitschrift für Klinische Pharmakologie Therapie und Toxikologie. International Journal of Clinical Pharmacology Therapy and Toxicology 4(1): 32-36